Terms: = Ovarian cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
51 results:
1. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract] [Full Text] [Related]
2. Development of an Automatic Rule-Based Algorithm for the Detection of ovarian cancer Recurrence From Electronic Health Records.
Lee S; Kim JH; Ha HI; Lim MC; Cho H
JCO Clin Cancer Inform; 2024 Mar; 8():e2300150. PubMed ID: 38442323
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
Huang D; Ke L; Cui H; Li S; Sun F
BMC Womens Health; 2024 Jan; 24(1):34. PubMed ID: 38218775
[TBL] [Abstract] [Full Text] [Related]
5. Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States.
Blackie K; Bobe G; Takata Y
J Health Popul Nutr; 2023 Nov; 42(1):130. PubMed ID: 37996932
[TBL] [Abstract] [Full Text] [Related]
6. MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for ccnd2 with ELAVL1.
Zhang H; Yuan N; Che H; Cheng X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):69-74. PubMed ID: 37300687
[TBL] [Abstract] [Full Text] [Related]
7. Profiling the metabolome of uterine fluid for early detection of ovarian cancer.
Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H; Li M
Cell Rep Med; 2023 Jun; 4(6):101061. PubMed ID: 37267943
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Effectiveness as well as Advantages and Disadvantages of Different Dimensions of Hysterosalpingo-Contrast Sonography for Diagnosis of Lesions Associated with Female Infertility.
Pei R
Comput Math Methods Med; 2022; 2022():7508880. PubMed ID: 36164612
[TBL] [Abstract] [Full Text] [Related]
9. Early drug development in solid tumours: analysis of National cancer Institute-sponsored phase 1 trials.
Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
[TBL] [Abstract] [Full Text] [Related]
10. Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis.
Ikeda Y; Yoshihara M; Yoshikawa N; Yokoi A; Tamauchi S; Nishino K; Niimi K; Kajiyama H
BMC Womens Health; 2022 Mar; 22(1):80. PubMed ID: 35313889
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis.
Yang J; Jin Y; Cheng S; Wang C; Zhang N; Huang S; Zhao Y; Wang Y
J Ovarian Res; 2021 Aug; 14(1):106. PubMed ID: 34404438
[TBL] [Abstract] [Full Text] [Related]
12. The flavonoid, kaempferol-3-O-apiofuranosyl-7-O-rhamnopyranosyl, as a potential therapeutic agent for breast cancer with a promoting effect on ovarian function.
Harrath AH; Jalouli M; Oueslati MH; Farah MA; Feriani A; Aldahmash W; Aldawood N; Al-Anazi K; Falodah F; Swelum A; Alwasel S
Phytother Res; 2021 Nov; 35(11):6170-6180. PubMed ID: 33908658
[TBL] [Abstract] [Full Text] [Related]
13. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Piccart M; van 't Veer LJ; Poncet C; Lopes Cardozo JMN; Delaloge S; Pierga JY; Vuylsteke P; Brain E; Vrijaldenhoven S; Neijenhuis PA; Causeret S; Smilde TJ; Viale G; Glas AM; Delorenzi M; Sotiriou C; Rubio IT; Kümmel S; Zoppoli G; Thompson AM; Matos E; Zaman K; Hilbers F; Fumagalli D; Ravdin P; Knox S; Tryfonidis K; Peric A; Meulemans B; Bogaerts J; Cardoso F; Rutgers EJT
Lancet Oncol; 2021 Apr; 22(4):476-488. PubMed ID: 33721561
[TBL] [Abstract] [Full Text] [Related]
14. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract] [Full Text] [Related]
15. Insomnia and its association with quality of life in women with ovarian cancer.
Ross TL; DeFazio A; Friedlander M; Grant P; Nagle CM; Williams M; Webb PM; Beesley VL;
Gynecol Oncol; 2020 Sep; 158(3):760-768. PubMed ID: 32653100
[TBL] [Abstract] [Full Text] [Related]
16. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract] [Full Text] [Related]
17. miR‑145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting ccnd2 and E2F3.
Hua M; Qin Y; Sheng M; Cui X; Chen W; Zhong J; Yan J; Chen Y
Mol Med Rep; 2019 May; 19(5):3575-3583. PubMed ID: 30864742
[TBL] [Abstract] [Full Text] [Related]
18. Identification of Potential Biomarkers and Metabolic Profiling of Serum in ovarian cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract] [Full Text] [Related]
19. Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.
Zeydan B; Tosakulwong N; Schwarz CG; Senjem ML; Gunter JL; Reid RI; Gazzuola Rocca L; Lesnick TG; Smith CY; Bailey KR; Lowe VJ; Roberts RO; Jack CR; Petersen RC; Miller VM; Mielke MM; Rocca WA; Kantarci K
JAMA Neurol; 2019 Jan; 76(1):95-100. PubMed ID: 30326011
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA HOTAIR Regulates CCND1 and ccnd2 Expression by Sponging miR-206 in ovarian cancer.
Chang L; Guo R; Yuan Z; Shi H; Zhang D
Cell Physiol Biochem; 2018; 49(4):1289-1303. PubMed ID: 30205383
[TBL] [Abstract] [Full Text] [Related]
[Next]
